Thursday, July 9, 2009

Bevacizumab for NF2 associated AN

An interesting article yesterday at NEJM, in which investigators at MGH gave bevacizumab to 10 patients with NF2 associated acoustic neuromas (vestibular schwannomas). 9/10 had reduction in tumor size after administration and 4/7 evaluable for changes in hearing had an improvement. Very interesting data, and may be useful in large tumors that would be difficult to treat with either surgery or RT.

No comments: